Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6011.5000 -59.50 (-0.98%)
NSE Jan 23, 2026 15:31 PM
Volume: 460.5K
 

6011.50
-0.98%
Axis Direct
Q4 revenue declined 3% YoY in line with our estimate, while EBITDA adjusted for Rs 290 mn of forex loss at Rs 3.9 bn was 9% below our estimate. Adj. PAT declined 10% YoY at Rs 2.88 bn, 12% below our estimate.
Divi's Laboratories .. has an average target of 6270.00 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended